bioRxiv Science⌕ Search

Biology subjects

Jones, R. T.

Publications and source records attributed to Jones, R. T..

2 recordsLinked to original sources

Laboratory efficacy of a solar-powered spatial repellent device against Anopheles mosquitoes

Spatial repellents represent a promising approach to complement existing malaria vector control interventions by reducing contact between mosquitoes and humans. However, the efficacy of passive spatial repellent devices may be affected by environmental conditions, particularly temperature and airflow, which can influence the release of volatile active ingredients. Active-release devices may provide more consistent delivery of spatial repellent compounds. We investigated the efficacy of a commercially available battery-powered spatial repellent device and a low-power solar-powered device designed for potential use in Africa. Laboratory trials were conducted to evaluate the efficacy of the two spatial repellent devices against Anopheles mosquitoes. Protective efficacy was assessed by comparing mosquito probing on human participants during spatial-repellent and control tests. The effect of the devices on mosquito entry into the test chamber was also assessed. The protective efficacy was 86% with the commercial battery-powered device and 80% with the low-power solar-powered device. A Wilcoxon rank-sum test showed that there was no significant difference between the performance of the two devices in terms of protective efficacy (p = 0.856) or entry inhibition (p = 0.7989). The low-power device could be charged using a small, household-level photovoltaic panel, to provide a potentially practical means of delivering spatial repellents in off-grid settings.

ecology↗

The M1 aminopeptidase NPEPPS is a novel regulator of cisplatin sensitivity

There is an unmet need to improve efficacy of platinum-based cancer chemotherapy. Using multi-omic assessment of cisplatin-responsive and -resistant human bladder cancer cell lines and whole-genome CRISPR screens, we identified Puromycin-Sensitive Aminopeptidase, NPEPPS, as a novel driver of cisplatin resistance. NPEPPS depletion sensitizes resistant bladder cancer cells to cisplatin in vitro and in vivo. Conversely, overexpression of NPEPPS in sensitive cells increased cisplatin resistance. We show that NPEPPS affects treatment response by regulating intracellular cisplatin concentrations. Patient-derived organoids (PDOs) generated from bladder cancer samples before and after cisplatin-based treatment, and from patients who did not receive cisplatin, were evaluated for sensitivity to cisplatin and they were found to be concordant with clinical response. In PDOs, shRNA depletion or pharmacologic inhibition of NPEPPS led to increased cisplatin sensitivity, while NPEPPS overexpression had the opposite effect. Our data present NPEPPS as a novel and druggable driver of cisplatin resistance by regulating intracellular cisplatin concentrations, along with providing the preclinical data to support clinical trials combining NPEPPS inhibition with cisplatin.

cancer biology↗